日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reprogramming encapsulins into modular carbon-fixing nanocompartments

将封装蛋白重新编程为模块化碳固定纳米隔室

Szyszka, Taylor N; Wijaya, Davin S; Siddiquee, Rezwan; Loustau, Alex; Rhodes, Timothy; Paul, Nathan; Whitney, Spencer M; Lau, Yu Heng

Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific

替贝他福司(一种T细胞受体-CD3双特异性抗体)治疗期间肿瘤免疫图谱的演变

Joseph J Sacco,Peter Kirk,Emma Leach,Alexander N Shoushtari,Richard D Carvajal,Camille Britton-Rivet,Sophie Khakoo,Laura Collins,Luis de la Cruz-Merino,Zeynep Eroglu,Alexandra P Ikeguchi,Paul Nathan,Omid Hamid,Marcus O Butler,Sarah Stanhope,Koustubh Ranade,Takami Sato

Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients

转移性葡萄膜黑色素瘤患者接受替苯他福司治疗后不良事件的发生率及处理:410例患者的汇总安全性分析

Takami Sato,Marcus O Butler,Sophie Piperno-Neumann,Jessica C Hassel,Paul Nathan,Alexander N Shoushtari,Piotr Rutkowski,Richard D Carvajal,Jean-Francois Baurain,Max Schlaak,Josep M Piulats,Ryan J Sullivan,Sebastian Ochsenreither,Reinhard Dummer,John M Kirkwood,Alexandra Ikeguchi,Anthony M Joshua,Mark R Middleton,Ramakrishna Edukulla,Constance Pfeiffer,Joseph J Sacco

Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial

尼洛替尼治疗 KIT 驱动的晚期黑色素瘤:II 期单臂 NICAM 试验结果

James Larkin, Richard Marais, Nuria Porta, David Gonzalez de Castro, Lisa Parsons, Christina Messiou, Gordon Stamp, Lisa Thompson, Kim Edmonds, Sarah Sarker, Jane Banerji, Paul Lorigan, Thomas R Jeffry Evans, Pippa Corrie, Ernest Marshall, Mark R Middleton, Paul Nathan, Steve Nicholson, Christian Ot

The Science (or Nonscience) of Research Into Sudden Infant Death Syndrome (SIDS)

婴儿猝死综合征(SIDS)研究的科学性(或非科学性)

Goldwater, Paul Nathan

COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma

COMPARZ事后分析:帕唑帕尼治疗晚期肾细胞癌患者的特征分析

Sternberg, Cora N; Motzer, Robert J; Hutson, Thomas E; Choueiri, Toni K; Kollmannsberger, Christian; Bjarnason, Georg A; Paul Nathan; Porta, Camillo; Grünwald, Viktor; Dezzani, Luca; Han, Jackie; Tannir, Nizar M

Variations in disability and quality of life with age and sex between eight lower income and middle-income countries: data from the INDEPTH WHO-SAGE collaboration

八个中低收入国家中,残疾和生活质量随年龄和性别的变化:来自 INDEPTH WHO-SAGE 合作项目的数据

Gomez-Olive, Francesc Xavier; Schröders, Julia; Aboderin, Isabella; Byass, Peter; Chatterji, Somnath; Davies, Justine I; Debpuur, Cornelius; Hirve, Siddhivinayak; Hodgson, Abraham; Juvekar, Sanjay; Kahn, Kathleen; Kowal, Paul; Nathan, Rose; Ng, Nawi; Razzaque, Abdur; Sankoh, Osman; Streatfield, Peter K; Tollman, Stephen M; Wilopo, Siswanto A; Witham, Miles D

Infection: the neglected paradigm in SIDS research

感染:婴儿猝死综合征研究中被忽视的范式

Goldwater, Paul Nathan

Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer

考布他汀 A4 磷酸盐 (CA4P) 与贝伐单抗联合治疗晚期癌症患者的 I 期临床试验

Paul Nathan, Martin Zweifel, Anwar R Padhani, Dow-Mu Koh, Matthew Ng, David J Collins, Adrian Harris, Craig Carden, Jon Smythe, Nita Fisher, N Jane Taylor, J James Stirling, Shiao-Ping Lu, Martin O Leach, Gordon J S Rustin, Ian Judson

S-nitroso proteome of Mycobacterium tuberculosis: Enzymes of intermediary metabolism and antioxidant defense

结核分枝杆菌的S-亚硝基蛋白质组:中间代谢和抗氧化防御酶

Rhee, Kyu Y; Erdjument-Bromage, Hediye; Tempst, Paul; Nathan, Carl F